Scancell Holdings Plc Stock Market Value
| SCNLF Stock | USD 0.19 0.00 0.00% |
| Symbol | Scancell |
Scancell Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scancell Holdings' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scancell Holdings.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Scancell Holdings on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Scancell Holdings plc or generate 0.0% return on investment in Scancell Holdings over 90 days. Scancell Holdings is related to or competes with Innate Pharma, NDT Pharmaceuticals, Molecular Partners, Brii Biosciences, Hofseth BioCare, Kintor Pharmaceutical, and NervGen Pharma. Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vac... More
Scancell Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scancell Holdings' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scancell Holdings plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1072 | |||
| Maximum Drawdown | 35.71 |
Scancell Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scancell Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scancell Holdings' standard deviation. In reality, there are many statistical measures that can use Scancell Holdings historical prices to predict the future Scancell Holdings' volatility.| Risk Adjusted Performance | 0.1075 | |||
| Jensen Alpha | 0.5531 | |||
| Total Risk Alpha | 0.2046 | |||
| Treynor Ratio | (1.45) |
Scancell Holdings February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1075 | |||
| Market Risk Adjusted Performance | (1.44) | |||
| Mean Deviation | 1.07 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.33 | |||
| Information Ratio | 0.1072 | |||
| Jensen Alpha | 0.5531 | |||
| Total Risk Alpha | 0.2046 | |||
| Treynor Ratio | (1.45) | |||
| Maximum Drawdown | 35.71 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Scancell Holdings plc Backtested Returns
Scancell Holdings appears to be out of control, given 3 months investment horizon. Scancell Holdings plc owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. By inspecting Scancell Holdings' technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please review Scancell Holdings' Variance of 19.33, risk adjusted performance of 0.1075, and Coefficient Of Variation of 812.4 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Scancell Holdings holds a performance score of 9. The entity has a beta of -0.37, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Scancell Holdings are expected to decrease at a much lower rate. During the bear market, Scancell Holdings is likely to outperform the market. Please check Scancell Holdings' mean deviation, information ratio, as well as the relationship between the Information Ratio and kurtosis , to make a quick decision on whether Scancell Holdings' existing price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Scancell Holdings plc has no correlation between past and present. Overlapping area represents the amount of predictability between Scancell Holdings time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scancell Holdings plc price movement. The serial correlation of 0.0 indicates that just 0.0% of current Scancell Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Scancell Pink Sheet
Scancell Holdings financial ratios help investors to determine whether Scancell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scancell with respect to the benefits of owning Scancell Holdings security.